Insider Acquisition: Phillip Frost Acquired 30,000 Shares of OPKO Health, Inc. (OPK); Nantahala Capital Management Increased By $16.04 Million Its Scientific Games (Call) (SGMS) Position

Scientific Games Corporation (NASDAQ:SGMS) Logo

Nantahala Capital Management Llc increased Scientific Games Corp (Call) (SGMS) stake by 16.62% reported in 2018Q1 SEC filing. Nantahala Capital Management Llc acquired 391,200 shares as Scientific Games Corp (Call) (SGMS)’s stock rose 27.27%. The Nantahala Capital Management Llc holds 2.75 million shares with $114.20M value, up from 2.35M last quarter. Scientific Games Corp (Call) now has $4.88B valuation. The stock decreased 1.28% or $0.7 during the last trading session, reaching $53.8. About 802,150 shares traded. Scientific Games Corporation (NASDAQ:SGMS) has risen 153.47% since June 22, 2017 and is uptrending. It has outperformed by 140.90% the S&P500. Some Historical SGMS News: 28/03/2018 – New Scientific Games Lottery Retail Innovation Debuts in 8 States; 12/03/2018 – Scientific Games Names Robert O’Connor Senior Vice President of Government Affairs; 14/03/2018 – Scientific Games Closes Above 50-Day Moving Average: Technicals; 06/03/2018 – Scientific Games Announces New SG Digital Leadership Appointments to Accelerate Global Product Strategy; 16/04/2018 – SCIENTIFIC GAMES – SG DIGITAL HAS COMMENCED SPORTSBOOK PRODUCT REVIEW SESSIONS WITH NEW JERSEY’S DIVISION OF GAMING ENFORCEMENT; 16/03/2018 – SCIENTIFIC GAMES REPORTS LAUNCH OF NATIONAL LOTTERY OF KAZAKHST; 30/04/2018 – Eight More Years! Scientific Games Will Continue To Bring Instant Game Entertainment To Kentucky Lottery Players; 03/04/2018 – Symphony Solutions Announces Partnership with Scientific Games Digital; 03/04/2018 – SYMPHONY SOLUTIONS PARTNERSHIP W/ SCIENTIFIC GAMES DIGITAL; 17/04/2018 – Scientific Games Launches Online Sports Betting Platform For Szerencsejáték Zrt., Hungary’s State-Owned Lottery And Largest G

Nantahala Capital Management Llc decreased Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stake by 91,372 shares to 308,628 valued at $1.72M in 2018Q1. It also reduced Ishares Tr (Put) (IWM) stake by 1.37M shares and now owns 1.67 million shares. Bancorp Inc Del (NASDAQ:TBBK) was reduced too.

More important recent Scientific Games Corporation (NASDAQ:SGMS) news were published by: which released: “SG Digital to Provide BCLC with Upgraded Sportsbook Solutions” on June 19, 2018, also published article titled: “Charting a jagged June breakout attempt, Nasdaq challenges record territory”, published: “Scientific Games (SGMS) to Implement Delaware Lottery Full-Scale Sports Betting Expansion Following PASPA Ruling” on June 01, 2018. More interesting news about Scientific Games Corporation (NASDAQ:SGMS) was released by: and their article: “SG Gaming and Ladbrokes Coral Group Agree Momentous 7-Year Deal” with publication date: June 15, 2018.

Investors sentiment decreased to 0.92 in Q1 2018. Its down 0.09, from 1.01 in 2017Q4. It fall, as 26 investors sold SGMS shares while 69 reduced holdings. 35 funds opened positions while 52 raised stakes. 53.71 million shares or 0.40% more from 53.50 million shares in 2017Q4 were reported. Profund Lc holds 8,482 shares. Oregon Employees Retirement Fund holds 19,952 shares or 0.01% of its portfolio. Wells Fargo Company Mn has 294,184 shares. Strs Ohio holds 2,700 shares. Mutual Of America Mngmt Ltd Liability reported 42,523 shares. Financial Bank Of Mellon owns 571,877 shares. California-based Schwab Charles Inv Incorporated has invested 0.01% in Scientific Games Corporation (NASDAQ:SGMS). Teachers Retirement Of The State Of Kentucky invested in 8,362 shares or 0% of the stock. Cornerstone Advisors holds 0% or 13 shares in its portfolio. Tiaa Cref Inv Management Ltd Liability Company stated it has 128,663 shares or 0% of all its holdings. 316 are owned by Tci Wealth Advsr. J Goldman & LP reported 0.02% stake. Comerica Commercial Bank invested 0.01% of its portfolio in Scientific Games Corporation (NASDAQ:SGMS). Tudor Et Al reported 13,568 shares. Alpha Windward Limited reported 300 shares.

Among 10 analysts covering Scientific Games Corp (NASDAQ:SGMS), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. Scientific Games Corp had 25 analyst reports since August 5, 2015 according to SRatingsIntel. Macquarie Research downgraded Scientific Games Corporation (NASDAQ:SGMS) on Friday, December 16 to “Neutral” rating. The company was maintained on Wednesday, August 5 by Deutsche Bank. Bank of America maintained the stock with “Buy” rating in Friday, March 2 report. The firm has “Hold” rating given on Friday, February 2 by Stifel Nicolaus. As per Tuesday, September 1, the company rating was upgraded by Deutsche Bank. The stock has “Buy” rating by Sterne Agee CRT on Monday, September 21. JP Morgan maintained the stock with “Neutral” rating in Friday, September 25 report. The rating was downgraded by Bank of America on Tuesday, January 12 to “Underperform”. The stock of Scientific Games Corporation (NASDAQ:SGMS) earned “Neutral” rating by Janney Capital on Monday, August 24. The stock has “Hold” rating by Stifel Nicolaus on Thursday, July 13.

Since March 5, 2018, it had 0 insider buys, and 10 insider sales for $23.67 million activity. On Monday, March 5 the insider COHEN PETER A sold $1.23 million. Isaacs Michael Gavin sold $2.29M worth of stock or 50,600 shares. 84,174 shares valued at $5.04 million were sold by Mooberry Derik on Wednesday, May 16. HADDRILL RICHARD M sold $2.08M worth of stock. Shares for $250,923 were sold by Winterscheidt Michael on Thursday, June 14. Kennedy David L sold $2.35 million worth of stock.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company has market cap of $2.50 billion. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. It currently has negative earnings. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform.

The stock decreased 6.89% or $0.33 during the last trading session, reaching $4.46. About 4.56M shares traded. OPKO Health, Inc. (NASDAQ:OPK) has declined 41.73% since June 22, 2017 and is downtrending. It has underperformed by 54.30% the S&P500. Some Historical OPK News: 18/05/2018 – OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test; 01/05/2018 – OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories; 23/03/2018 – OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes; 18/05/2018 – OPKO: Draft Determiniation by Medicare Contractor Novitas Is Subject to Public Comment Period Ending July 5; 08/05/2018 – OPKO Health 1Q Loss/Shr 8c; 18/05/2018 – OPKO Said Earlier That Novitas Solutions Proposed Non-Coverage Policy for 4KScore Test for Medicare in Draft Determination; 16/03/2018 OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in Europ; 27/04/2018 – OPKO HEALTH – HAVE SPOKEN WITH CO’S ISRAEL-BASED INVESTORS; THEY EXPRESSED DESIRE CO CONTINUE PRESENCE ON TASE AND URGED CO TO RECONSIDER DECISION; 27/04/2018 – OPKO Health: Withdraws Its Request to Voluntarily Delist Its Common Stk From the TASE; 21/04/2018 – DJ OPKO Health Inc, Inst Holders, 1Q 2018 (OPK)

Phillip Frost currently the CEO & Chairman of Opko Health Inc recently bought 30,000 shares of the Florida-based company. The new insider deal has $136,200 USD total value, at an average stock price per share of $4.5. He also acquired 248,199 shares worth approximately $978,973 USD in the last 30 days. Phillip Frost’s investment was completed on June 22, 2018 and was made public inside a Form 4 at the U.S. SEC’s website. Phillip Frost presently owns 191.37 million shares or 34.21% of the company’s total market capitalization.

Analysts await OPKO Health, Inc. (NASDAQ:OPK) to report earnings on August, 14. They expect $-0.07 EPS, down 75.00% or $0.03 from last year’s $-0.04 per share. After $-0.08 actual EPS reported by OPKO Health, Inc. for the previous quarter, Wall Street now forecasts -12.50% EPS growth.

Since January 22, 2018, it had 66 insider purchases, and 0 selling transactions for $12.52 million activity. Shares for $279,689 were bought by FROST PHILLIP MD ET AL on Tuesday, March 27. $37,125 worth of OPKO Health, Inc. (NASDAQ:OPK) was bought by Fishel Robert Scott on Wednesday, April 25. Rubin Steven D had bought 6,000 shares worth $19,500 on Wednesday, March 7. 2,065 shares were bought by Logal Adam, worth $7,011 on Tuesday, March 13.

Another recent and important OPKO Health, Inc. (NASDAQ:OPK) news was published by which published an article titled: “Why OPKO Health, Inc. Stock Rocketed Higher in May” on June 09, 2018.

OPKO Health, Inc. (NASDAQ:OPK) Institutional Positions Chart